Effects of Prepartum Immunotropic Treatment on Growth Performance, Physiological Status, and Early-Life Adaptation of Holstein Calves

The present study evaluated the effects of the prepartum administration of immunotropic preparations on the growth performance, physiological status, and metabolic profile of calves. Sixty pregnant Holstein cows were divided into three groups (n = 20 each): the first experimental group received a single intramuscular injection of sodium nucleinate (5 mL), the second experimental group received a single intramuscular injection of Ribotan (5 mL), and the control group received saline solution. All treatments were administered 3–9 days before calving. The obtained calves were monitored until 60 days of age. Clinical, growth, hematological, and biochemical parameters were assessed at days 1, 10, 30, and 60. Calves from the treated cows showed improved neonatal adaptation, including faster development of standing posture and the suckling reflex. Body weight was significantly higher in experimental groups at 30 and 60 days (p ≤ 0.05), with consistently greater average daily gains. Blood analysis revealed increased total protein, albumin, and γ-globulin levels, indicating enhanced protein metabolism and immune status. In contrast, cortisol concentrations were lower in treated groups, reflecting reduced physiological stress. Multivariate (PCA) and correlation analyses confirmed strong associations between growth performance, metabolic activity, and immune indicators, and demonstrated clear separation between control and treated groups. Ribotan exhibited the most pronounced biological effect, while sodium nucleinate showed moderate but consistent improvements. In conclusion, prepartum immunotropic treatment of cows enhances early-life adaptation, metabolic efficiency, and growth performance of calves and may represent a practical strategy for improving calf rearing outcomes in dairy farming systems.